Peace. Excellent commentary on lifescience sector investing. Indeed PYC could do so much more by regular ANNs. What I have observed that regular updates from the chairman have dried up as soon as the last CR was over.
It logically follows that management do not feel the need to blow the trumpet anymore.
From this is it right to deduce that: A. no more CRs (ofcourse) B. SP is no longer critical for takeover scenario. Offers for takeover would ignore current SP in calculations as it is not the right component for any calculations anyway? C. A very important business deal is very close to completion, and management is waiting for the result for an ANN. (Roche agreeing to take the option of licencing BBB peptide)? Or perhaps Roche offering takeover?. The inevitable delays due to negotiations/ legal formalities?
Personally, I would rather PYC d'ont keep blowing the trumpet without anything new to announce.
C.
PYC Price at posting:
6.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)